"In a final pilot study, Associate Professor Blancafort tested the activity of Phylogica’s CPP fusion in an in vivo breast cancer model. A substantial reduction in tumour size was observed in tumours injected with Phylogica’s CPP fusion when compared to controls. This pilot study needs to be repeated using larger groups to confirm its significance."
Hmmm 58 days now post this release using the graphic in the TIDES '15 presentation it looks like the pilot was around 14 day duration - I wonder if they moved straight into the follow up or it's still on the table - you'd expect there should be an update some time soon.
Ann: Cancer pilot study success, page-97
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $204.0K | 1.605M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89666 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 405959 | 4 |
View Market Depth
| Last trade - 15.46pm 11/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |